Future Market Insights suggests that within the glucose oxidase landscape, the dual application across industrial enzyme processing and medical biosensor technology is creating a market with two distinct demand engines operating at different growth velocities. FMI analysts identify the convergence of antibiotic replacement in animal feed and continuous glucose monitoring in human health as the central pivot point for the industry, effectively splitting the market into a high-volume feed segment and a high-value diagnostics segment.